Velano Vascular adds corporate veteran to board of directors

Velano Vascular, a Philadelphia-based transformative-venipuncture technology firm, said on Wednesday that 35-year industry veteran David Schlotterbeck has been named to its board of directors. Schotterbeck brings a strong executive background, having served as chairman and CEO of three public and two private firms, completing two successful IPOs, securing $7 billion in mergers and acquisitions, and creating $11 billion in shareholder value over a decade. Read More »